Mark T. Marino

791 total citations
30 papers, 593 citations indexed

About

Mark T. Marino is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Mark T. Marino has authored 30 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Oncology. Recurrent topics in Mark T. Marino's work include Drug Transport and Resistance Mechanisms (4 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pesticide Exposure and Toxicity (4 papers). Mark T. Marino is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Pesticide Exposure and Toxicity (4 papers). Mark T. Marino collaborates with scholars based in United States, United Kingdom and Germany. Mark T. Marino's co-authors include Peter Jeffrey Conn, Melton B. Affrime, Samir K. Gupta, Christopher Banfield, Josephine Lim, Anders Boss, R Baughman, James Cassidy, Diane Costello and Klaus Rave and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Hepatology.

In The Last Decade

Mark T. Marino

30 papers receiving 547 citations

Peers

Mark T. Marino
Saul Lowitt United States
R. A. Yates United Kingdom
Masataka Tajima Japan
Anne Wu United States
J. Rosenthaler Japan
Tomas Mow Denmark
Gilles‐Jacques Rivière Switzerland
Jacek Spławiński Poland
M. De Luise Australia
Evangelos Balafas Greece
Saul Lowitt United States
Mark T. Marino
Citations per year, relative to Mark T. Marino Mark T. Marino (= 1×) peers Saul Lowitt

Countries citing papers authored by Mark T. Marino

Since Specialization
Citations

This map shows the geographic impact of Mark T. Marino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Marino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Marino more than expected).

Fields of papers citing papers by Mark T. Marino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Marino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Marino. The network helps show where Mark T. Marino may publish in the future.

Co-authorship network of co-authors of Mark T. Marino

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Marino. A scholar is included among the top collaborators of Mark T. Marino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Marino. Mark T. Marino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cassidy, James, Stephen D. Luzio, Mark T. Marino, & R Baughman. (2012). Quantification of human serum insulin concentrations in clinical pharmacokinetic or bioequivalence studies: what defines the “best method”?. Clinical Chemistry and Laboratory Medicine (CCLM). 50(4). 663–6. 10 indexed citations
3.
Cassidy, James, Nikhil Amin, Mark T. Marino, et al.. (2011). Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration. Pharmaceutical Research. 28(9). 2157–2164. 52 indexed citations
4.
Marino, Mark T., Diane Costello, R Baughman, et al.. (2010). Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes. Clinical Pharmacology & Therapeutics. 88(2). 243–250. 30 indexed citations
5.
Marino, Mark T., James Cassidy, R Baughman, Anders Boss, & Peter Richardson. (2010). A new C‐peptide correction model used to assess bioavailability of regular human insulin. Biopharmaceutics & Drug Disposition. 31(7). 428–435. 2 indexed citations
6.
Rave, Klaus, et al.. (2009). Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin. Diabetes Obesity and Metabolism. 11(7). 715–720. 61 indexed citations
7.
Marino, Mark T. & Peter Jeffrey Conn. (2005). Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Current Opinion in Pharmacology. 6(1). 98–102. 88 indexed citations
8.
Liang, Earvin, et al.. (2003). Pharmacokinetics of E5564, a Lipopolysaccharide Antagonist, in Patients with Impaired Hepatic Function. The Journal of Clinical Pharmacology. 43(12). 1361–1369. 6 indexed citations
9.
Banfield, Christopher, Samir K. Gupta, Mark T. Marino, Josephine Lim, & Melton B. Affrime. (2002). Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not Desloratadine. Clinical Pharmacokinetics. 41(4). 311–318. 73 indexed citations
10.
Gupta, Samir K., Christopher Banfield, Bhavna Kantesaria, et al.. (2001). Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study. Clinical Therapeutics. 23(3). 451–466. 57 indexed citations
11.
Zhou, Honghui, Tianling Chen, Mark T. Marino, et al.. (2000). Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects. British Journal of Clinical Pharmacology. 50(6). 543–552. 9 indexed citations
12.
Pitcairn, Gary R., et al.. (2000). Regional lung deposition of a technetium 99m-labeled formulation of mometasone furoate administered by hydrofluoroalkane 227 metered-dose inhaler. Clinical Therapeutics. 22(12). 1483–1493. 28 indexed citations
13.
Marino, Mark T., et al.. (1998). High-performance liquid chromatographic determination of N-[2- (hydroxyethyl)-N-(2-(7-guaninyl)ethyl)]methylamine, a reaction product between nitrogen mustard and DNA and its application to biological samples. Journal of Chromatography B Biomedical Sciences and Applications. 716(1-2). 187–193. 12 indexed citations
14.
Katial, Rohit, et al.. (1998). A Drug Interaction Between Zafirlukast and Theophylline. Archives of Internal Medicine. 158(15). 1713–1713. 20 indexed citations
15.
Marino, Mark T., Brian G. Schuster, Ralf P. Brueckner, et al.. (1998). Population Pharmacokinetics and Pharmacodynamics of Pyridostigmine Bromide for Prophylaxis against Nerve Agents in Humans. The Journal of Clinical Pharmacology. 38(3). 227–235. 42 indexed citations
16.
Takimoto, Chris H., William L. Dahut, Mark T. Marino, et al.. (1997). Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.. Journal of Clinical Oncology. 15(4). 1492–1501. 39 indexed citations
17.
Marino, Mark T., et al.. (1994). Pharmacokinetics and kinetic-dynamic modeling of an 8-aminoquinoline candidate anticyanide and antimalarial drug (WR242511).. Drug Metabolism and Disposition. 22(3). 358–366. 5 indexed citations
18.
Marino, Mark T., James O. Peggins, & Thomas G. Brewer. (1993). High-performance liquid chromatographic method for the determination of a candidate 8-aminoquinoline antimalarial drug (WR 242511) using oxidative electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 616(2). 338–343. 2 indexed citations
19.
Marino, Mark T., et al.. (1993). Hypercalcaemia and elevated levels of parathyroid hormone‐related protein in cutaneous squamous/basal cell carcinoma. Journal of Internal Medicine. 233(2). 205–207. 12 indexed citations
20.
Marino, Mark T.. (1990). Mees' Lines. Archives of Dermatology. 126(6). 827–827. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saul Lowitt Breakdown of academic impact, for papers by R. A. Yates Breakdown of academic impact, for papers by Masataka Tajima Breakdown of academic impact, for papers by Anne Wu Breakdown of academic impact, for papers by J. Rosenthaler Breakdown of academic impact, for papers by Tomas Mow Breakdown of academic impact, for papers by Gilles‐Jacques Rivière Breakdown of academic impact, for papers by Jacek Spławiński Breakdown of academic impact, for papers by M. De Luise Breakdown of academic impact, for papers by Evangelos Balafas
Rankless by CCL
2026